“Sofpironium Targets M3 Receptors In Vitro and Shows Early Clinically Meaningful Improvement in Primary Axillary Hyperhidrosis Symptoms”. SKIN The Journal of Cutaneous Medicine, vol. 9, no. 6, Nov. 2025, p. s717, https://doi.org/10.25251/kvstvq23.